前收市價 | 5.0000 |
開市 | 5.0000 |
買盤 | 3.6000 |
賣出價 | 8.5000 |
拍板 | 62.50 |
到期日 | 2024-10-18 |
今日波幅 | 5.0000 - 5.0000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.